Integras Partners LLC

Position in GILD — Gilead Sciences, Inc.

CIK 2055384 Alpharetta, GA

Position in GILD

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$3,151,677

-$280,030 QoQ

Shares Held

24,946

+1.3% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

3.63%

of 13F equity value

Holder Rank

#704

of 2,266 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Integras Partners LLC holds $14,287,432 across 5 Drug Manufacturers - General names. GILD ranks #4 (22.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	15,318	$3,854,621
2	AMGN	Amgen Inc	9,675	$3,503,511
3	BMY	Bristol Myers Squibb Co	59,474	$3,426,891
4	GILD	Gilead Sciences, Inc. This page	24,946	$3,151,677
5	JNJ	Johnson & Johnson	1,381	$350,732

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,151,677	24,946	+1.3%	Shares	Sole	2026-07-24
2026-03-31	$3,431,707	24,623	-5.7%	Shares	Sole	2026-05-12
2025-12-31	$3,204,373	26,107	-4.4%	Shares	Sole	2026-01-29
2025-09-30	$3,030,744	27,304	+3.6%	Shares	Sole	2025-10-23
2025-06-30	$2,921,867	26,354	-0.6%	Shares	Sole	2025-08-12
2025-03-31	$2,970,781	26,513	-14.6%	Shares	Sole	2025-05-14
2024-12-31	$2,867,626	31,045	—	Shares	Sole	2025-02-10
No filing history on record for this holder in this stock.